531210 — Colinz Laboratories Income Statement
0.000.00%
Last trade - 00:00
- IN₹103.79m
- IN₹44.92m
- IN₹71.55m
- 77
- 52
- 52
- 68
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 76.7 | 76 | 61.6 | 69.7 | 71.5 |
Cost of Revenue | |||||
Gross Profit | 48.6 | 48.6 | 39.8 | 46.8 | 48.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 75.3 | 75 | 60.2 | 65.9 | 66.5 |
Operating Profit | 1.35 | 1.08 | 1.41 | 3.85 | 5.04 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.56 | 1.76 | 2.45 | 4.8 | 6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.22 | 1.3 | 2.08 | 3.39 | 4.57 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.22 | 1.3 | 2.08 | 3.39 | 4.57 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.22 | 1.3 | 2.08 | 3.39 | 4.57 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.266 | 0.368 | 0.454 | 0.74 | 1.89 |